Sandu Pharmaceuticals Ltd.
| BSE: 524703 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE751D01014 |
| BSE 00:00 | 06 Jul | 66.90 |
1.05 (1.59%) |
OPEN
65.15 |
HIGH
67.40 |
LOW
65.10 |
| NSE 05:30 | 01 Jan | Sandu Pharmaceuticals Ltd |
| OPEN | 65.15 |
| PREVIOUS CLOSE | 65.85 |
| VOLUME | 3429 |
| 52-Week high | 86.00 |
| 52-Week low | 43.35 |
| P/E | 37.17 |
| Mkt Cap.(Rs cr) | 59 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Sandu Pharmaceuticals Ltd. (SANDUPHARMA) - Announcements
-
Sandu Pharmaceuticals Ltd Board Meeting Intimation for Thursday 07Th July 2022
02/07/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
01/07/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
30/06/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Closure of Trading Window
27/06/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Related Party Transaction Disclosure Under Regulation 23(9) For Half Year Ended 31.03.2022
04/06/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Newspaper Publication In Respect Of The Audited Financial Results For The Q And Year Ended 31.03.202
01/06/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Statement Of Deviation And Variation Of Funds For Q Ended 31St March 2022
30/05/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Audited Financial Results For The Year Ended 31ST March 2022
30/05/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th May 2022
30/05/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
26/05/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
25/05/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Year Ended 31St M
15/05/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations An
23/04/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Certificate Under Regulation 40(9) Of SEBI (LODR) Regulation 2015 For The Year Ended 31St March 2022
20/04/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Trading Of 889667 Equity Shares Of Rs. 10/- Each Issued At A Premium Of Rs. 10.69/- BearingDistincti
18/04/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2022
18/04/2022 | bse
-
Sandu Pharmaceuticals Ltd Compliance Certificate For Q Ended 31St March 2022
08/04/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08/04/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
06/04/2022 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
05/04/2022 | bse |
Downlaod PDF
Quick Links for Sandu Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
